{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:22:25Z","timestamp":1772166145568,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Fund of Anhui Institute of Translational Medicine","award":["2017zhyx14"],"award-info":[{"award-number":["2017zhyx14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The objective of this study was to investigate whether unreasonable empirical antibiotic treatment (UEAT) had an impact on 30-day mortality and duration of hospitalization in bacterial pneumonia caused by carbapenem-resistant gram-negative bacteria (CRGNB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective cohort study involving CRGNB-infected pneumonia. All CRGNB-infected pneumonia patients received empirical and targeted antibiotic treatment (TAT), and they were divided into reasonable empirical antibiotic treatment (REAT) and UEAT according to whether the empirical antibiotic treatment (EAT) was reasonable. The data of the two groups were compared to analyze their influence on the 30-day mortality and hospitalization time in CRGNB-infected pneumonia patients. Moreover, we also considered other variables that might be relevant and conducted multivariable regression analysis of 30-day mortality and duration of hospitalization in CRGNB-infected pneumonia patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study collected 310 CRGNB-infected pneumonia patients, the most common bacterium is\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      (211\/310 [68%]), the rest were\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (46\/310 [15%]),\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      and others (53\/310 [17%]). Among them, 76\/310 (24.5%) patients received REAT. In the analysis of risk factors, dementia, consciousness were risk factors of 30-day mortality, pulmonary disease, hemodynamic support at culture taken day and recent surgery were risk factors for longer hospital stay. The analysis of 30-day mortality showed that UEAT was not associated with 30-day mortality for the 30-day mortality of REAT and UEAT were 9 of 76 (11.84%) and 36 of 234 (15.38%) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.447), respectively. Meanwhile, there was difference between REAT and UEAT (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.023) in the analysis of EAT on hospitalization time in CRGNB-infected pneumonia patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      UEAT was not associated with 30-day mortality while was related to duration of hospitalization in CRGNB-infected pneumonia patients, in which\n                      <jats:italic>Acinetobacter baumanniii<\/jats:italic>\n                      accouned for the majority.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-021-00421-2","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T10:02:41Z","timestamp":1615111361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect on 30-day mortality and duration of hospitalization of empirical antibiotic therapy in CRGNB-infected pneumonia"],"prefix":"10.1186","volume":"20","author":[{"given":"Rongrong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"issue":"6","key":"421_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/jac\/dkl372","volume":"58","author":"M Paul","year":"2006","unstructured":"Paul M, Andreassen S, Tacconelli E, et al. Improving empirical antibiotic treatment using TREAT, a computerized decision support system:cluster randomized trial. Antimicrob Chemother. 2006;58(6):1238\u201345.","journal-title":"Antimicrob Chemother"},{"issue":"8","key":"421_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2015.06.024","volume":"37","author":"WI Sligl","year":"2015","unstructured":"Sligl WI, Dragan T, Smith SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Infect Dis. 2015;37(8):129\u201334.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"421_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s15010-013-0462-7","volume":"41","author":"M Melzer","year":"2013","unstructured":"Melzer M, Welch C. 30-day mortality in UK patients with bacteraemic community-acquired pneumonia. Infection. 2013;41(5):1005\u201311.","journal-title":"Infection"},{"issue":"4","key":"421_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijantimicag.2017.12.013","volume":"51","author":"E Carrara","year":"2018","unstructured":"Carrara E, Pfeffer I, Zusman O, et al. Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis. Int J Antimicrob Agents. 2018;51(4):548\u201353.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"421_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1471-2334-12-308","volume":"12","author":"SY Park","year":"2012","unstructured":"Park SY, Park HJ, Moon SM, et al. Impact of adequate empirical combination therapy on mortalit from bacteremic Pseudomonas aeruginosa pneumonia. BMC Infect Dis. 2012;12(11):308.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"421_CR6","first-page":"1815","volume":"67","author":"Y Zak-Doron","year":"2018","unstructured":"Zak-Doron Y, Dishon Benattar Y, Pfeffer I, et al. The Association between empirical antibiotic treatment and mortality in severe infections caused by carbapenem-resistant gram-negative bacteria: a prospective study. Clin Infect Dis. 2018;67(12):1815\u201323.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"421_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3109\/00365548.2013.775479","volume":"45","author":"CI Kang","year":"2013","unstructured":"Kang CI, Wi YM, Ko KS, et al. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy. Scand J Infect Dis. 2013;45(7):519\u201325.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"421_CR8","first-page":"29","volume":"68","author":"N Eliakim-Raz","year":"2019","unstructured":"Eliakim-Raz N, Babitch T, Shaw E, et al. Risk factors for treatment failure and mortality among hospitalized patients with complicated urinary tract infection: a multicenter retrospective cohort study (RESCUING Study Group). Clin Infect Dis. 2019;68(1):29\u201336.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"421_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12879-016-1650-8","volume":"16","author":"YK Yoon","year":"2016","unstructured":"Yoon YK, Park DW, Sohn JW, et al. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis. BMC Infect Dis. 2016;16(7):331.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"421_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/cid\/ciw504","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, et al. Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):575\u201382.","journal-title":"Clin Infect Dis"},{"issue":"08","key":"421_CR11","first-page":"1263","volume":"29","author":"L Guo","year":"2019","unstructured":"Guo L, Fengjing Hu, Cai L, et al. Current status and risk assessment of nosocomial infections in critical medicine. Chin J Nosocomol. 2019;29(08):1263\u20136.","journal-title":"Chin J Nosocomol"},{"issue":"6","key":"421_CR12","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2147\/CIA.S197146","volume":"14","author":"Y Xu","year":"2019","unstructured":"Xu Y, Lai C, Xu G, et al. Risk factors of ventilator-associated pneumonia in elderly patients receiving mechanical ventilation. Clin Interv Aging. 2019;14(6):1027\u2013103.","journal-title":"Clin Interv Aging"},{"issue":"10","key":"421_CR13","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.mayocp.2016.06.024","volume":"91","author":"B Guti\u00e9rrez-Guti\u00e9rrez","year":"2016","unstructured":"Guti\u00e9rrez-Guti\u00e9rrez B, Salamanca E, de Cueto M, et al. A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae. Mayo Clin Proc. 2016;91(10):1362\u201371.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"421_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.idh.2019.02.001","volume":"24","author":"CL Lim","year":"2019","unstructured":"Lim CL, Spelman D. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital. Infect Dis Health. 2019;24(3):124\u201333.","journal-title":"Infect Dis Health"},{"issue":"10","key":"421_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cmi.2019.02.027","volume":"25","author":"JB Wiggers","year":"2019","unstructured":"Wiggers JB, Sehgal P, Pinto R, et al. The association of adequate empirical treatment and time to recovery from bacteraemic urinary tract infections: a retrospective cohort study. Clin Microbiol Infect. 2019;25(10):1253\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"421_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2334-14-161","volume":"14","author":"YJ Kim","year":"2014","unstructured":"Kim YJ, Jun YH, Kim YR, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy. BMC Infect Dis. 2014;14(3):161.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"421_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jmii.2014.05.003","volume":"49","author":"WL Cheng","year":"2016","unstructured":"Cheng WL, Hsueh PR, Lee CC, et al. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: appropriateness of empirical treatment matters. J Microbiol Immunol Infect. 2016;49(2):208\u201315.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"421_CR18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4103\/1817-1737.164302","volume":"10","author":"HM Al-Dorzi","year":"2015","unstructured":"Al-Dorzi HM, Asiri AM, Shimemri A, et al. Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia. Ann Thoracic Med. 2015;10(4):256\u201362.","journal-title":"Ann Thoracic Med"},{"issue":"11","key":"421_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1471-2334-12-308","volume":"12","author":"SY Park","year":"2012","unstructured":"Park SY, Park HJ, Moon SM, et al. Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia. BMC Infect Dis. 2012;12(11):308.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"421_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.diagmicrobio.2010.10.013","volume":"69","author":"EA Neuner","year":"2011","unstructured":"Neuner EA, Yeh JY, Hall GS, et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis. 2011;69(4):357\u201362.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"421_CR21","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00134-018-5360-0","volume":"44","author":"G Bertolini","year":"2018","unstructured":"Bertolini G, Nattino G, et al. Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection. Intensive Care Med. 2018;44(10):1709\u201319.","journal-title":"Intensive Care Med"},{"issue":"1","key":"421_CR22","doi-asserted-by":"crossref","first-page":"e01577","DOI":"10.1128\/AAC.01577-17","volume":"62","author":"ST Micek","year":"2018","unstructured":"Micek ST, Hampton N. Risk factors and outcomes for ineffective empiric treatment of sepsis caused by gram-negative pathogens: stratification by onset of infection. Antimicrob Agents Chemother. 2018;62(1):e01577-e1617.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"421_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10096-017-3117-2","volume":"37","author":"R Murri","year":"2018","unstructured":"Murri R, Taccari F, Spanu T, et al. A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections. Eur J Clin Microbiol Infect Dis. 2018;37(1):167\u201373.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-021-00421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12941-021-00421-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-021-00421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T11:05:50Z","timestamp":1724583950000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-021-00421-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1186\/s12941-021-00421-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-146124\/v1","asserted-by":"object"}]},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,7]]},"assertion":[{"value":"10 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the medical ethics committee of the First Affiliated Hospital of Anhui Medical University (the reference number:Quick-PJ 2019\u201312-18) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}